Treating neonatal rats with 6-hydroxydopamine induced an increase in voluntary alcohol consumption

Citation
K. Yoshimoto et al., Treating neonatal rats with 6-hydroxydopamine induced an increase in voluntary alcohol consumption, ALC CLIN EX, 23(4), 1999, pp. 2S-6S
Citations number
19
Categorie Soggetti
Clinical Psycology & Psychiatry","Neurosciences & Behavoir
Journal title
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
ISSN journal
01456008 → ACNP
Volume
23
Issue
4
Year of publication
1999
Supplement
S
Pages
2S - 6S
Database
ISI
SICI code
0145-6008(199904)23:4<2S:TNRW6I>2.0.ZU;2-W
Abstract
Brain dopamine (DA) and serotonin (5-HT) neurotransmission have been implic ated in the mediation of alcohol-seeking behavior. We examined the effects of treatment of neonatal rats (3 days after birth) with the neurotoxin 6-hy droxydopamine (6-OHDA; 100 mu g/10 mu l, intracerebroventricularly) on the relationship between the levels of neurotransmitters and alcohol drinking b ehavior at the age of 14 weeks. 6-OHDA treatment reduced the levels of DA a nd its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in the nucleus acc umbens (ACC), frontal cortex, striatum (STR), tegmentum/substantia nigra, a nd dorsal raphe nucleus. 5-HT levels in the ACC and STR were increased in t he 6-OHDA-treated rats. 6-OHDA-treated rats showed increased alcohol consum ption. There was a significant change in the ratio of [5-hydraxyindoleaceti c acid]/[5-HT] in the ACC and STR of the treated rats, but no difference in the ratio of [DOPAC]/[DA] between the sham-operated controls and treated r ats. 6-OHDA-treated rats bah dopaminergic dysfunction in the five brain reg ions related to the reward system, in part, and a decrease in 5-HT turnover , including the accumulation of 5-HT in the ACC and STR. Furthermore, basal . extracellular releases of DA and 5-HT of the ACC were significantly lower Ih the 6-OHDA-treated rats, compared with the controls. It was suggested t hat alcohol seeking behavior is associated with the alterations of dopamine rgic neurons and the release of 5-HT in the mesocorticolimbic system.